The emerging role of telomerase in cardiac muscle cell growth and survival

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 7, 2002, Pages 717-724

  Oh, Hidemasa ^a   Schneider, Michael D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adenovirus; Apoptosis; Cell cycle; Hypertrophy; Transgenic

Indexed keywords

TELOMERASE;

APOPTOSIS; ARTICLE; CAPPING PHENOMENON; CELL DEATH; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CHROMOSOME; ENZYME SYNTHESIS; GENOME; GERM CELL; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; ISCHEMIC HEART DISEASE; MAMMAL CELL; MUSCLE REGENERATION; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SENESCENCE; STEM CELL; TELOMERE; TUMOR CELL;

ADENOVIRIDAE; MAMMALIA;

EID: 0036660844     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2018     Document Type: Article

References (74)

1. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83: 1-14.
2. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998; 83: 15-26.
3. Kang PM, Izumo S. Apoptosis and heart failure: A critical review of the literature. Circ Res 2000; 86: 1107-1113.
4. MacLellan WR, Schneider MD. The Cardiac Cell Cycle. In: Harvey RP, Rosenthal N, eds. Cardiac Development 1998. San Diego, CA: Academic Press: 405-427.
5. MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 2000; 62: 289-320.
6. Oh H, Taffet GE, Youker KA, Entman ML, Overbeek PA, Michael LH, Schneider MD. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci USA 2001; 98: 10308-10313.
7. Nugent CI, Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev 1998; 12: 1073-1085.
8. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000; 34: 331-358.
9. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-673.
10. Shay JW, Wright WE. Aging. When do telomeres matter? Science 2001; 291: 839-840.
11. Stewart SA, Weinberg RA. Senescence: does it all happen at the ends? Oncogene 2002; 21: 627-630.
12. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
13. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JHM, Meyerson M, Weinberg RA. Inhibition of telomerase limits the growth of human cancer cells. Nature Med 1999; 5: 1164-1170.
14. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279; 349-352.
15. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 1998; 95: 14723-14728.
16. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998; 8: 279-282.
17. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396: 84-88.
18. Kirshenbaum LA, Schneider MD. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem 1995; 270: 7791-7794.
19. Agah R, Kirshenbaum LA, Truong LD, Chakraborty S, Abdellatif M, Michael LH, Schneider MD. Adenoviral delivery of E2F-1 directs cell cycle re-entry and p53-independent apoptosis in post-mitotic adult myocardium in vivo. J Clin Invest 1997; 100: 2722-2728.
20. Akli S, Zhan S, Abdellatif M, Schneider MD. E1A can provoke G1 exit that is refractory to p21 and independent of activating Cdk2. Circ Res 1999; 85: 319-328.
21. Poolman RA, Li JM, Durand B, Brooks G. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27(KIP1) knockout mice. Circ Res 1999; 85: 117-127.
22. Burton PB, Raff MC, Kerr P, Yacoub MH, Barton PJ. An intrinsic timer that controls cell-cycle withdrawal in cultured cardiac myocytes. Dev Biol 1999; 216: 659-670.
23. Pasumarthi KB, Tsai SC, Field LJ. Coexpression of mutant p53 and p193 renders embryonic stem cell-derived cardiomyocytes responsive to the growth-promoting activities of adenoviral E1A. Circ Res 2001; 88: 1004-1011.
24. Greider CW. Telomeres do D-loop-t-loop. Cell 1999; 97: 419-422.
25. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, De Lange T. Mammalian telomeres end in a large duplex loop. Cell 1999; 97: 503-514.
26. Liu Y, Snow BE, Hande MP, Yeung D, Erdmann NJ, Wakeham A, Itie A, Siderovski DP, Lansdorp PM, Robinson MO, Harrington L. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol 2000; 10: 1459-1462.
27. Stansel RM, De Lange T, Griffith JD. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 2001; 20: 5532-5540.
28. Smogorzewska A, Van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, De Lange T. Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 2000; 20: 1659-1668.
29. Van Steensel B, Smogorzewska A, De Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998; 92: 401-413.
30. Van Steensel B, De Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997; 385: 740-743.
31. Baumann P, Cech TR. Pot1. the putative telomere end-binding protein in fission yeast and humans. Science 2001; 292: 1171-1175.
32. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000; 403: 795-800.
33. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995; 92: 4818-4822.
34. Martin-Rivera L, Herrera E, Albar JP, Blasco MA. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc Natl Acad Sci USA 1998; 95: 10471-10476.
35. Borges A, Liew CC. Telomerase activity during cardiac development. J Mol Cell Cardiol 1997; 29: 2717-2724.
36. Coviello-McLaughlin GM, Prowse KR. Telomere length regulation during postnatal development and ageing in Mus spretus. Nucleic Acids Res 1997; 25: 3051-3058.
37. Hemann MT, Greider CW. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res 2000; 28: 4474-4478.
38. Gasser SM. A sense of the end. Science 2000; 288: 1377-1379.
39. De Lange T. Protection of mammalian telomeres. Oncogene 2002; 21: 532-540.
40. Zhu J, Wang H, Bishop JM, Blackburn EH. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci USA 1999; 96: 3723-3728.
41. Prescott JC, Blackburn EH. Telomerase RNA template mutations reveal sequence-specific requirements for the activation and repression of telomerase action at telomeres. Mol Cell Biol 2000; 20: 2941-2948.
42. Sherr CJ, DePinho RA. Cellular senescence; mitotic clock or culture shock? Cell 2000; 102: 407-410.
43. Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, Shay JW, Wright WE. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev 2001; 15: 398-403.
44. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91: 25-34.
45. Niida H, Shinkai Y, Hande MP, Matsumoto T, Takehara S, Tachibana M, Oshimura M, Lansdorp PM, Furuichi Y. Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol Cell Biol 2000; 20: 4115-4127.
46. Lee HW, Blasco MA, Gottlieb GJ, Horner JW. 2nd, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392: 569-574.
47. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999; 96: 701-712.
48. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000; 287: 1253-1258.
49. Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, Bouffler SD, Blasco MA. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 2000; 192: 1625-1636.
50. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, Depinho RA. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406: 641-645.
51. Hemann MT, Rudolph KL, Strong MA, DePinho RA, Chin L, Greider CW. Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol Biol Cell 2001; 12: 2023-2030.
52. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999; 97: 527-538.
53. Fu W, Begley JG, Killen MW, Mattson MP. Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 1999; 274: 7264-7271.
54. Zhu H, Fu W, Mattson MP. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J Neurochem 2000; 75: 117-124.
55. Lu C, Fu W, Mattson MP. Telomerase protects developing neurons against DNA damage-induced cell death. Brain Res Dev Brain Res 2001; 131: 167-171.
56. Herbert B, Pitts AE, Baker SI, Hamilton SE, Wright WE, Shay JW, Corey DR. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci USA 1999; 96: 14276-14281.
57. Volarevic S, Thomas G. Role of S6 phosphorylation and S6 kinase in cell growth. Prog Nucleic Acid Res Mol Biol 2000; 65: 101-127.
58. Sadoshima J, Izumo S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro: Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res 1995; 77: 1040-1052.
59. Oh H, Fujio Y, Kunisada K, Hirota H, Matsui H, Kishimoto T, Yamauchi-Takihara K. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J Biol Chem 1998; 273: 9703-9710.
60. Zhao YY, Sawyer DR, Baliga RR, Opel DJ, Han XQ, Marchionni MA, Kelly RA, Neuregulins promote survival and growth of cardiac myocytes-Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 1998; 273: 10261-10269.
61. Schultz JE, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M, Pawlowski SA, Lorenz JN, Kimball TR, Doetschman T. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 1999; 104: 709-719.
62. Vogel H, Lim DS, Karsenty G, Finegold M, Hasty P. Deletion of Ku86 causes early onset of senescence in mice [In Process Citation]. Proc Natl Acad Sci USA 1999; 96: 10770-10775.
63. Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG, Benchimol S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase, EMBO J 1997; 16: 6018-6033.
64. Karlseder J, Broccoli D, Dai Y, Hardy S, De Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283: 1321-1325.
65. Kishi S, Lu KP. A critical role for Pin2/TRF1 in ATM-dependent regulation. Inhibition of Pin2/TRF1 function complements telomere shortening, radio-sensitivity, and the G2/M checkpoint defect of ataxia-telangiectasia cells. J Biol Chem 2002; 277: 7420-7429.
66. Baur JA, Zou Y, Shay JW, Wright WE. Telomere position effect in human cells. Science 2001; 292: 2075-2077.
67. Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 2001; 493: 21-25.
68. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu CP, Herron GS. Human endothelial cell life extension by telomerase expression. J Biol Chem 1999; 274: 26141-26148.
69. Matsushita H, Chang E, Glassford AJ, Cooke JP, Chiu CP, Tsao PS. eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res 2001; 89: 793-798.
70. Yang J, Nagavarapu U, Relloma K, Sjaastad MD, Moss WC, Passaniti A, Herron GS. Telomerized human microvasculature is functional in vivo. Nat Biotechnol 2001; 19: 219-224.
71. Franco S, Segura I, Riese HH, Blasco MA. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres. Cancer Res 2002; 62: 552-559.
72. González-Suárez E, Samper E, Ramírez A, Flores JM, Martín-Caballero J, Jorcano JL, Blasco MA. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 2001; 20: 2619-2630.
73. Notaro R, Cimmino A, Tabarini D, Rotoli B, Luzzatto L. In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci USA 1997; 94: 13782-13785.
74. Allsopp RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med 2001; 193: 917-924.